2019 AVBCC Summit Agenda

October 16-18, 2019

New York Athletic Club, New York, NY

Coming Soon!

The 2019 AVBCC Summit agenda is not available at this time. Please check back again soon.

Download 2018 Summit Agenda

2018 Summit Agenda

Day 1 – Tuesday, October 30, 2018

6:30 am – 7:30 am	Conference Registration
6:30 am – 7:30 am	Networking Breakfast
7:30 am	Opening Remarks and Greeting Burt Zweigenhaft, Co-Chair, AVBCC Michael Kolodziej, Co-Chair, AVBCC William McGivney, Co-Chair, AVBCC Jayson Slotnik, Co-Chair, AVBCC
7:30 am – 8:30 am	Keynote
8:30 am – 9:15 am	Tomorrow’s Cancer Care: A Government Policy Perspective Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies Faculty: Randy Burkholder, VP, Policy and Research, PhRMA Crystal Kuntz, VP, Healthcare Policy and Research, Biotechnology Innovation Organization (BIO) A. Mark Fendrick, MD, Director, Center for Value-Based Insurance Design, University of Michigan
9:15 am – 10:00 am	Tomorrow’s Cancer Care: An Insurance Payer’s Perspective Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Steve Peskin, MD, MBA, FACP, Executive Medical Director, Population Health, Horizon BCBS William (Bill) Winkenwerder, Jr, MD, Chairman, CitiusTech and former CEO, Highmark Health
10:00 am – 10:45 am	Tomorrow’s Cancer Care: A Center of Excellence Perspective Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors Faculty: Al Benson III, MD, FACP, FASCO, Northwestern Medicine Maurie Markman, MD, President, CTCA Medicine & Science
10:45 am – 11:15 am	Tomorrow’s Cancer Care: The Community-Based Care Perspective Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Barry Brooks, MD, Medical Director, US Oncology Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers Jeffrey Scott, MD, CMO, Integra Connect, LLC
11:15 am – 12:00 pm	Keynote: Cancer Drug Trend Report Doug Long, VP, Industry Relations, IQVIA
12:00 pm – 12:45 pm	Keynote: Cancer Care into the Future Greg Simon, President, Biden Cancer Initiative
12:45 pm – 1:30 pm	Tomorrow’s Cancer Care: The Employer Perspective Moderator: F. Randy Vogenberg, PhD, RPh, Principal, Institute for Integrated Healthcare (IIH) Faculty: Michael Thompson, President & CEO, National Alliance of Healthcare Purchaser Coalitions Patricia Goldsmith, CEO, CancerCare Optimizing Patient Services: Solutions in Cancer Care Moderator: Douglas Bock, Partner, Archbow Consulting Faculty: Sumner Madden, Senior Director, Access360, AstraZeneca Michael Fitzgibbons, CEO, Claritas Rx Tara Herington, RN, VP, Sonexus™ Access and Patient Support, Cardinal Health
1:30 pm – 2:15 pm	Tomorrow’s Cancer Care: A Pharma Perspective Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors Faculty: Axel Hoos, MD, SVP, Head, Oncology R&D, GlaxoSmithKline Kim Blackwell, MD, VP, Early Phase Development & Immuno-oncology, Eli Lilly & Co
Track 1: CLINICAL Track 2: TECHNOLOGY Track 3: SUPPLY CHAIN Track 4: BUSINESS Track 5: CONTRACTING Track 6: SPECIALTY PHARMACY Track 7: CARE MANAGEMENT Track 8: INDUSTRY SURVEY
2:15 pm – 3:15 pm	BREAKOUT 1: CLINICAL Cell-Based Immunotherapies Moderator: Morrie Ruffin, CEO, Adjuvant Partners Faculty: Alfred Slanetz, PhD, CEO, Genius Biotechnology Kim Noonan, PhD, Founder & CSO, WindMIL Therapeutics Sean Tunis, MD, MSc, Founder & CEO, Center for Medical Technology Policy Kimberly Freeman, VP, Global Commercial Strategy, Adaptimmune Greg Russotti, PhD, VP, Cell Therapy Technical Development, Celgene Corporation BREAKOUT 2: TECHNOLOGY Applying Machine Learning to Aid Decision-Making in Cancer Treatment Moderator: Annatasiah Mhaka, PhD, Senior Advisor, Adjuvant Partners, and Co-Founder, Alliance for Artificial Intelligence In Healthcare Faculty: George Daneker, MD, CMO, Cancer Treatment Centers of America William A. Flood, MD, MSc, CMO, eviti NantHealth Robert S. Miller, MD, VP & Medical Director, CancerLinQ, American Society of Clinical Oncology Rohit Borker, PhD, VP & Head, Health Economics and Outcomes Research, US Oncology: Novartis Pharmaceuticals Corporation Ben Newton, PhD, Global Head, GE Healthcare Life Sciences Molecular Imaging BREAKOUT 3: SUPPLY CHAIN Oncology Supply Chain Moderator: Kevin Cast, Partner, Archbow Consulting Faculty: Randy Maloziec, VP, Bio Services, US Bioservices, an AmerisourceBergen Specialty Company Lisa Harrison, Senior Director, Pharmacy and Clinical Services, ION Solutions Nick Calla, RPh, Esq, VP, Industry Relations, Cardinal Health Specialty Solutions BREAKOUT 4: CARE MANAGEMENT The Patient Voice and Advocate Perspective Moderator: Robert Goldberg, PhD, CEO, Thrive HealthRx Faculty: Daniel Klein, President & CEO, Patient Access Network Foundation Clorinda Walley, CEO, Chronic Disease Fund Patricia Goldsmith, CEO, CancerCare Elizabeth Franklin, LGSW, ACSW, Executive Director, Cancer Policy Institute, Cancer Support Community
3:15 pm – 4:15 pm	BREAKOUT 5: SUPPLY CHAIN CAR-T Pipeline and Market Access Moderator: Morrie Ruffin, CEO, Adjuvant Partners Faculty: Amy DuRoss, MBA, Co-Founder & CEO, Vineti Joel Brill, MD, CMO, Predictive Health, LLC Bob Charles, BS, MBA, Founder/Principal The GeneriSys Company Greta Stone, Deputy VP, Policy & Research, PhRMA BREAKOUT 6: TECHNOLOGY Big Data: “The New Oil” Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Marcus Neubauer, MD, VP & Medical Director, Value-Based Reimbursement, McKesson Specialty Health Susan Weidner, MS, SVP, IntrinsiQ Specialty Solutions, AmerisourceBergen Ash Malik, President, Life Sciences Division, Integra Connect, LLC BREAKOUT 7: CONTRACTING Update on the CMS Oncology Care Model and Other Oncology Alternative Payment Models Moderator: Pamela Pelizzari, MPH, Healthcare Consultant, Milliman Faculty: Michael Ruiz de Somocurcio, MBA, VP, Payer & Provider Collaboration, Regional Cancer Care Associates Dennis P. Scanlon, PhD, Distinguished Professor of Health Policy & Administration, The Pennsylvania State University BREAKOUT 8: BUSINESS The Burden of Cancer Care: Financial & Nonfinancial Costs Associated with Cancer Diagnosis & Treatment Moderator: Christine Ferro, CHFP, Healthcare Analytics Consultant, Milliman Faculty: Danielle Bubnis, Senior Director, Advocacy, Leukemia & Lymphoma Society
4:15 pm – 5:00 pm	BREAKOUT 9: CLINICAL Genomics and Personalized Medicine Moderator: Louis Jacques, MD, Chief Clinical Officer, ADVI Health LLC Faculty: Stan Skrzypczak, VP, Corporate Development & Reimbursement, Guardant Health Edward Abrahams, PhD, President, Personalized Medicine Coalition David Spetzler, MS, PhD, MBA, President & CSO, Caris Life Sciences John Simmons, PhD, Director, Translational Science and Diagnostics, PGDx Rachel Anhorn, PharmD, Director, Payer Policy and Health Outcomes, Foundation Medicine BREAKOUT 10: CONTRACTING Value-Based Oncology Care Moderator: Jude Gallagher, PA, MBA, Former Director, Complex Clinical Care Strategy, Humana Faculty: Brian Bourbeau, MBA, LSSBB, Associate Director, Business Metrics and Analysis, American Society of Clinical Oncology (ASCO) Virginia Calega, MD, MBA, FACP, VP, Medical Management & Policy, Independence Blue Cross Dennis P. Scanlon, PhD, Distinguished Professor of Health Policy & Administration, The Pennsylvania State University Ed Saltzman, Executive Chairman and Founder, Defined Health BREAKOUT 11: TECHNOLOGY Delivering Precision Medicine with New Digital Technologies Moderator: Jeff Lombardo, PharmD, BCOP, Associate Director, Empire State Patient Safety Assurance Network Faculty: Andrew Norden, CMO, Cota Healthcare Eric Sredzinski, EVP, Clinical and Quality Assurance, Avella Specialty Pharmacy Scooter Plowman, MD, MBA, MHSA, Medical Director, Proteus Digital Health BREAKOUT 12: SPECIALTY PHARMACY A Vision for Pharma Value-Based Drug Contracting Moderator: Tom Michaels, SVP, Sales, Vivaleas Faculty: Michael Reff, RPh, MBA, Executive Director & Founder, NCODA Ray Bailey, Director of Pharmacy, Florida Cancer Specialists Matt Farber, Senior Director, Patient Care & Advocacy, Oncology & Fertility, Walgreens
5:00 pm – 6:00 pm	Keynote Rowdy Gaines, Three-Time Olympic Gold Medalist and NBC Sports Commentator Rob Butcher, Executive Director, Swim Across America Steve Lundquist, 4-time Olympic Gold Medalist & World-Record Holder Distinguished Researchers Panel: Moderator: Neil Canavan, Author, A Cure Within Panelists: Jedd Wolchok, MD, Memorial Sloan Kettering Cancer Center Luis Diaz, MD, Memorial Sloan Kettering Cancer Center Axel Hoos, MD, President, Oncology, GlaxoSmithKline
6:00 pm – 9:00 pm	Evening Network Reception: High-Value Auction Event to benefit Swim Across America: Making Waves to Fight Cancer Book Signing: Neil Canavan, MSc, Author, A Cure Within

Day 2 – Wednesday, October 31, 2018

6:30 am – 7:00 am	Networking Breakfast
7:00 am – 7:50 am	Oncology Drug Pipeline Overview, Next 3 Years Moderator: Jeffrey Bockman, PhD, EVP, Oncology Practice Head, Defined Health, a Cello Health business Faculty: Michael R. Mong, PharmD, Director, Specialty Pharmacy Development, Walgreen Co. Cheryl Allen, BSPharm, MBA, VP, Industry Relations, Diplomat Pharmacy
7:50 am – 8:00 am	Opening Remarks Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
8:00 am – 9:00 am	Oncology Drug Benefits into the Future Moderator: Kevin Cast, Partner, Archbow Consulting Faculty: Everett Neville, RPh, EVP, Strategy, Supply Chain & Specialty, Express Scripts Surya Singh, MD, Corporate VP, Head, Medical Benefit Management, CVS Caremark Scott Reid, PharmD, eviCore Healthcare C. Lyn Fitzgerald, SVP, US & Global Development, National Comprehensive Cancer Network
Track 1: CLINICAL Track 2: TECHNOLOGY Track 3: SUPPLY CHAIN Track 4: BUSINESS Track 5: CONTRACTING Track 6: SPECIALTY PHARMACY Track 7: CARE MANAGEMENT Track 8: INDUSTRY SURVEY
9:00 am – 10:00 am	BREAKOUT 1: SUPPLY CHAIN Strategies for Delivering on Pharmaceutical Value, a Focus on Quality Moderator: Darin Rubin, CEO, Managing Director, The Dedham Group LLC Faculty: Danielle Ziernicki, BS, RPh, PharmD, National Quality Forum, Steering Committee for Cancer Project, The Dedham Group LLC Ira Klein, MD, MBA, FACP, Senior Director, Healthcare Quality Strategy, J&J Health Care Systems Norris Turner, PharmD, PhD, VP, Strategic Alliances and Measure Implementation, Pharmacy Quality Alliance BREAKOUT 2: CLINICAL Biosimilars and Impact on Cancer Care Moderator: Robert Rifkin, MD, Medical Director, Biosimilars, US Oncology Network Faculty: William Yoon, PharmD, MBA, Executive Director & Head, US Medical Managed Markets & Strategic Alliances, Sandoz John Kelton, PharmD, Biosimilars Medical Director, Pfizer Chrys Kokino, Global Commercial Head, Biologics & Insulins, Mylan Chad Pettit, Biosimilars Value and Access, Amgen BREAKOUT 3: BUSINESS The Pharma Food Chain—Driver of Inflation or Obstacle to Innovation? Moderator: Bruce Pyenson, FSA, MAAA, Principal and Consulting Actuary, Milliman Faculty: Richard Evans, Founder and General Manager, SSR LLC Brian DeBusk, CEO & President, DeRoyal; Vice Chair, Lincoln Memorial University; Commissioner, MedPAC Anna Kaltenboeck, Program Director and Senior Health Economist, Center for Health Policy & Outcomes, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center BREAKOUT 4: CARE MANAGEMENT Standardized Measurements and Process for Navigating Cancer Care Faculty: Tricia Strusowski, MS, RN, Manager, Oncology Solutions; Chair, AONN+ Evidence into Practice Metrics Subcommittee Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
10:00 am – 11:00 am	From K Street to Wall Street: A Look at Cancer Policy Influence on Markets Moderator: Ipsita Smolinski, MBA, MPH, Managing Director, Capitol Street and McAllister & Quinn Faculty: Lisa Gill, Managing Director, Senior Analyst, Healthcare Technology & Distribution, JPMorgan Securities, Inc PNC Bank (TBA) Geoff Meacham, PhD, Managing Director, Biotech & Pharma Research, Barclays Radiology Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors Faculty: Michael DeLeo, MD, Chief of Radiology, Southern New Hampshire Medical, Chair and Medical Director, Department of Radiology, Hampshire Medical Raj Singla, MD, CMO, Radiation Therapy, eviCore Healthcare Ilya Gipp, MD, PhD, Oncology Solutions Executive, Philips HealthTech
11:00 am – 12:00 pm	View from Capitol Hill and State Capitals: Public Policy Outlook for Cancer Care Moderator: Lindsay Greenleaf, Director, ADVI Health LLC Faculty: John McManus, President & Founder, The McManus Group Kavita Patel, MD, Brookings Institution State panelists: Anthony Fiori, Managing Director, Manatt Health Kip Piper, MA, FACHE, President, Health Results Group, LLC Oncology Nurse & Nurse Navigators: Best Kept Secret in Value-Based Care Faculty: Brenda Nevidjon, RN, MSN, FAAN, CEO, Oncology Nursing Society Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
12:00 pm – 1:00 pm	Understanding Value Equations: Real-World Applications and Implications Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors Faculty: Peter Bach, MD, Director, Center for Health Policy & Outcomes, Memorial Sloan Kettering Cancer Center Anthony V. Coletta, MD, MBA, EVP, and President, Facilitated Health Networks, Independence Health Group Ravinder Dhawan, PhD, VP & Head, Oncology, Center for Observational & Real-World Evidence, Merck Amy Niles, VP, External Relations, Pan Foundation What Happens to a Cancer Patient, Stays with That Cancer Patient; When Will Physicians Accept Patient-Reported Data Into Their EMRs Moderator: Rick Lee, MHA, Chairman, CancerLife Faculty: Charlie Coltman, Founder, CancerLife Mark Soberman, MD, MBA, FACS, Chief Physician Executive, Monocacy Health Partners Theresa Schmidt, MA, PMP, CSPO, Director, Discern Health Gitesh Patel, Director, Global Business Development, Comprehensive Blood & Cancer Centers (CBCC)
1:00 pm – 2:00 pm	Clinical Decision Support in the Midst of Rapid Scientific Innovation Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Robert J. Green, MD, SVP, Clinical Oncology, Flatiron Health Charles Saunders, CEO, Integra Connect Marcus Neubauer, MD, VP, and Medical Director, Value-Based Reimbursement, McKesson Specialty Health Atul Dhir, MD, DPhil, CEO, New Century Health Patient Panel Moderator: Jill Pollander, Director of Patient Services, National Organization for Rare Disorders Faculty: Dennis P. Scanlon, PhD, Distinguished Professor of Health Policy & Administration, The Pennslvania State University Bob Tufts, Cancer Survivor and Professor, Yeshiva University Matthew Zachery, CEO, Stupid Cancer Jonny Imerman, Founder, Imerman Angels
2:00 pm – 2:45 pm	Keynote Clifford Hudis, MD, FACP, FASCO, CEO, American Society of Clinical Oncology
2:45 pm – 3:45 pm	BREAKOUT 5: TECHNOLOGY Blockchain and Use Cases in Cancer Healthcare Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies Faculty: Bob Charles, BS, MBA, The GeneriSys Company Jennifer Hinkel, Partner, McGivney Global Advisors BREAKOUT 6: SPECIALTY PHARMACY Role of the Specialty Pharmacy in Cancer Care Moderator: Sheila M. Arquette, RPH, Executive Director, National Association of Specialty Pharmacy Faculty: Paul Jardina, President & CEO, Onco360 Ray Bailey, Director of Pharmacy, Florida Cancer Specialists Josh Stein, MBA, CEO, AdhereTech Sheila Talty, RPh, MBA, Specialty Pharmacy, Business Development, Yale New Haven Health System BREAKOUT 7: INDUSTRY SURVEY Revitalizing Patient Cost-Sharing as a Benefit Control Tool: Results from an Industry Survey Melinda Haren, RN, Senior Director, Access Strategies, Zitter Health Insights BREAKOUT 8: BUSINESS How Patient Support Services and Payer Policies Impact Patient Decision-Making, Adherence, and Treatment in Oncology Moderator: Charles Stevens, Global Lead, ICON Access, Commercialisation & Communications/President MediMedia & Complete Healthcare Communications, ICONplc Faculty: Nicole Caswell, Executive Director of Operations, CoPilot Provider Services Edward Hensley, Chief Commercial Officer & Co-Founder, AssistRx Maggie Adamski, Senior Director, Patient Insights and Engagement, ICON Douglas Bock, Partner, Archbow Consulting
3:45 pm – 4:30 pm	Future Trends in the Cancer Care Ecosystem Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Brenton Fargnoli, MD, Medical Director, Flatiron Health J. Lance Grady, VP Team Lead, Market Access & Reimbursement, Avalere Health Bruce Gould, MD, Medical Director, Northwest Georgia Oncology Centers, P.C.
4:30 pm – 4:45 pm	Closing Remarks

*Agenda is subject to change.